{
    "doi": "https://doi.org/10.1182/blood-2021-150337",
    "article_title": "Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi ",
    "article_date": "November 5, 2021",
    "session_type": "626.Aggressive Lymphomas: Prospective Therapeutic Trials",
    "abstract_text": "Introduction Non-pegylated liposomal doxorubicin (NPLD) is considered a good alternative to conventional doxorubicin for the treatment of older patients (pts) with aggressive lymphomas and/or at high risk for cardiological toxicity. The use of R-COMP for the treatment of older pts with DLBCL has been supported by several small retrospective studies . In this report we describe the characteristics and outcomes of pts who were prospectively enrolled in the Elderly Project (EP) and who were treated with R-COMP and compared them with pts treated with conventional R-CHOP. Methods. This analysis was conducted starting from the dataset of the EP study. The use of NPLD was allowed according to 648/96 law, treatment decision was left to physician discretion and was independent of frailty status. For the purposes of this analysis, we included all pts who were treated with full doses of R-CHOP and R-COMP. The study endpoint were progression free survival (PFS) and overall survival (OS). A propensity score analysis was conducted to account for the main confounding factors. Results Overall 691 out of 1163 pts of the EP were treated with R-CHOP (383; 55%) or R-COMP (308; 45%); median age was 71 and 76 years for R-CHOP and R-COMP, respectively (p < 0.001) (Table 1). Pts were similarly distributed among different IPI groups for R-COMP or R-CHOP. Based on simplified Geriatric Assessment (sGA) 88%, 11% and <1% of the R-CHOP treated pts and 61%, 32% and 6% of the R-COMP pts were FIT, UNFIT, and FRAIL (p <0.001). Elderly Prognostic Index (EPI) score was low, intermediate, and high in 39%, 54% and 8% of R-CHOP pts and 27%, 49% and 24% of R-COMP pts (p <0.001). PFS at 3-years was 70% for R-CHOP and 64% for R-COMP (p=ns). OS at 3-years was 77% for R-CHOP and 71% for R-COMP (p=ns). The propensity score analysis was conducted in 610 pts and confirmed no significant differences in terms of PFS and OS in the comparison between R-CHOP and R-COMP treated pts (PFS; HR 1.17, 95% CI 0.84-1.63; OS: HR 1.04 95% CI 0.64-1.48). No differences were registered in terms of interruption of treatment due to toxicities (7% for R-CHOP and 11% for R-COMP). Conclusions Data from the prospective observational EP study did not show significant differences in terms of efficacy comparing R-COMP to standard R-CHOP. The higher frequency of UNFIT and FRAIL pts among those treated with NPLD suggests R-COMP is a good strategy to offer a curative treatment to these groups of pts. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Disclosures Merli:  EUSA Pharma: Other: Travel, Accomodations, Expenses; Roche: Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accomodations, Expenses; Takeda: Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accomodations, Expenses; MSD: Membership on an entity's Board of Directors or advisory committees; Gilead Science: Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accomodations, Expenses; Janssen: Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accomodations, Expenses; Celgene: Other: Travel, Accomodations, Expenses. Tucci:  janssen: Membership on an entity's Board of Directors or advisory committees; Gentili: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees. Rigacci:  Merck: Membership on an entity's Board of Directors or advisory committees; Abbvie: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; Takeda: Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accomodations, Expenses; Gilead Science: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Roche: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Menarini: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Cavallo:  ROCHE: Membership on an entity's Board of Directors or advisory committees; Servier: Speakers Bureau; Gilead: Speakers Bureau. Fabbri:  Servier/Pfizer: Honoraria; Takeda: Other: Travel, Accomodations, Expenses; Takeda: Honoraria. Puccini:  Takeda: Membership on an entity's Board of Directors or advisory committees. Ferrero:  Incyte: Membership on an entity's Board of Directors or advisory committees; Morphosys: Research Funding; Gilead: Research Funding, Speakers Bureau; Janssen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; EUSA Pharma: Consultancy, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Servier: Speakers Bureau; Clinigen: Membership on an entity's Board of Directors or advisory committees. Zilioli:  Roche, Italfarmaco: Consultancy, Honoraria; MSD, Janssen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accommodations; Gentili, Takeda, Gilead, Servier: Consultancy, Speakers Bureau; Takeda: Other: travel expenses, accommodation. Nassi:  Takeda: Consultancy; Kyowa Kirin: Consultancy; Incyte: Consultancy; Roche: Consultancy. Musuraca:  Janssen, Incyte, Roche: Consultancy; Janssen, Roche, Incyte: Membership on an entity's Board of Directors or advisory committees; Janssen, Roche, Incyte: Honoraria. Flenghi:  Janssen: Other: Travel, Accomodations, Expenses; Roche: Other: Travel, Accomodations, Expenses. Marcheselli:  sandoz: Membership on an entity's Board of Directors or advisory committees. Luminari:  Roche: Consultancy, Membership on an entity's Board of Directors or advisory committees; Celgene: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: Travel, Accomodations, Expenses; Janssen: Other: Travel, Accomodations, Expenses; Gilead: Consultancy, Membership on an entity's Board of Directors or advisory committees; Regeneron: Consultancy; GENELAB SRL: Consultancy.",
    "author_names": [
        "Francesco Merli",
        "Michele Spina",
        "Alessandra Tucci",
        "Luigi Rigacci",
        "Federica Cavallo",
        "Maria Giuseppina Cabras",
        "Isabel Alvarez",
        "Alberto Fabbri",
        "Alessandro Re",
        "Benedetta Puccini",
        "Simone Ferrero",
        "Sara Veronica Usai",
        "Angela Ferrari",
        "Emanuele Cencini",
        "Elsa Pennese",
        "Vittorio Ruggero Zilioli",
        "Dario Marino",
        "Monica Balzarotti",
        "M. Christina Cox",
        "Manuela Zanni",
        "Alice Di Rocco",
        "Arben Lleshi",
        "Barbara Botto",
        "Stefan Hohaus",
        "Michele Merli",
        "Roberto Sartori",
        "Guido Gini",
        "Luca Nassi",
        "Gerardo Musuraca",
        "Monica Tani",
        "Chiara Bottelli",
        "Sofia Kovalchuk",
        "Francesca Re",
        "Leonardo Flenghi",
        "Anna Lia Molinari",
        "Giuseppe Tarantini",
        "Emanuela Chimienti",
        "Luigi Marcheselli",
        "Caterina Mammi",
        "Stefano Luminari",
        "Annalisa Arcari"
    ],
    "author_dict_list": [
        {
            "author_name": "Francesco Merli",
            "author_affiliations": [
                "Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Michele Spina",
            "author_affiliations": [
                "Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandra Tucci",
            "author_affiliations": [
                "Hematology, Department of Hematology, ASST Spedali Civili, Brescia, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luigi Rigacci",
            "author_affiliations": [
                "Hematology Department, Lymphoma Unit, Careggi Hospital and University of Florence, Firenze, Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Federica Cavallo",
            "author_affiliations": [
                "Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Giuseppina Cabras",
            "author_affiliations": [
                "Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Isabel Alvarez",
            "author_affiliations": [
                "Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alberto Fabbri",
            "author_affiliations": [
                "Division of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Re",
            "author_affiliations": [
                "Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Benedetta Puccini",
            "author_affiliations": [
                "Hematology Department, Lymphoma Unit, Careggi Hospital and University of Florence, Firenze, Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Simone Ferrero",
            "author_affiliations": [
                "Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara Veronica Usai",
            "author_affiliations": [
                "Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angela Ferrari",
            "author_affiliations": [
                "Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emanuele Cencini",
            "author_affiliations": [
                "Division of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elsa Pennese",
            "author_affiliations": [
                "Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vittorio Ruggero Zilioli",
            "author_affiliations": [
                "Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dario Marino",
            "author_affiliations": [
                "Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS Padova, Padova, Italy"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Balzarotti",
            "author_affiliations": [
                "Department of Medical Oncology and Hematology, Humanitas Clinical and Research Hospital-IRCCS, Rozzano (MI), Italy"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "M. Christina Cox",
            "author_affiliations": [
                "Hematology unit, Azienda Ospedaliera-Universitaria Sant'Andrea, ROMA, Italy"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Manuela Zanni",
            "author_affiliations": [
                "Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alice Di Rocco",
            "author_affiliations": [
                "Department of Translational and Precision Medicine, University \"La Sapienza\", Roma, Italy"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arben Lleshi",
            "author_affiliations": [
                "Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Barbara Botto",
            "author_affiliations": [
                "Division of Hematology, Azienda Ospedaliera Universitaria Citt\u00e0 della Salute e della Scienza, Torino, Italy"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefan Hohaus",
            "author_affiliations": [
                "University Policlinico Gemelli Foundation, IRCCS, Catholic University of the Sacred Heart, Roma, Italy"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michele Merli",
            "author_affiliations": [
                "Hematology, University Hospital \"Ospedale di Circolo e Fondazione Macchi\" - ASST Sette Laghi, University of Insubria, Varese, Italy"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberto Sartori",
            "author_affiliations": [
                "Departement of Clinical and Experimental Oncology, Oncohematology Unit, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto (TV), Italy"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Gini",
            "author_affiliations": [
                "Division of Hematology, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luca Nassi",
            "author_affiliations": [
                "Division of Hematology, Department of Translational Medicine, AOU Maggiore della Carit\u00e0 and University of Eastern Piedmont, Novara, Italy"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gerardo Musuraca",
            "author_affiliations": [
                "Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \"Dino Amadori\", Meldola, Italy"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Tani",
            "author_affiliations": [
                "Hematology Unit, Ospedale Santa Maria delle Croci, Ravenna, Italy"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chiara Bottelli",
            "author_affiliations": [
                "Hematology, ASST Spedali Civili di Brescia, Brescia, Italy"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sofia Kovalchuk",
            "author_affiliations": [
                "Hematology Department, Lymphoma Unit, Careggi Hospital and University of Florence, Firenze, Italy"
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Re",
            "author_affiliations": [
                "Hematology and CTMO, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy"
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Leonardo Flenghi",
            "author_affiliations": [
                "Hematology, S. Maria della Misericordia Hospital, Perugia, Italy"
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna Lia Molinari",
            "author_affiliations": [
                "Hematology Unit, Ospedale degli Infermi, Rimini, Italy"
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Tarantini",
            "author_affiliations": [
                "Hematology and BMT Unit, \"Monsignor R. Dimiccoli\" Hospital, Barletta, Italy"
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emanuela Chimienti",
            "author_affiliations": [
                "Division of Medical Oncology and Immune-related Tumors, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy"
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luigi Marcheselli",
            "author_affiliations": [
                "Fondazione Italiana Linfomi (FIL) Onlus, Modena, Italy"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Caterina Mammi",
            "author_affiliations": [
                "Gruppo Amici dell'Ematologia GRADE-Onlus Foundation, Reggio Emilia, Italy"
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Luminari",
            "author_affiliations": [
                "Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy"
            ],
            "author_rank": 40,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Annalisa Arcari",
            "author_affiliations": [
                "Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy"
            ],
            "author_rank": 41,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-21T21:36:27",
    "is_scraped": "1"
}